Imiphumela emibi ye-Remicade (i-Infliximab)

Le-Biologic Therapy ye-IBD Ihlangene Nezinye Imiphumela Ezingezansi

Kuyini Ukubuyisela?

I-Remicade (infliximab) yi- TNF-alpha yokuqala (i-tumor necrosis factor alpha) -blocker ezovunyelwa ukuphatha isifo sofuba esiswini (IBD) . Izidakamizwa ze-TNF-alpha zisetshenziselwa ukwelapha isifo sikaCrohn kanye nesifo sofuba ngenxa yokuthi abantu abane-IBD baye baboniswa ukuthi bane-TNF-alpha engaphezu kwemizimba yabo kunabantu abangenayo i-IBD.

I-Remicade inikezwa ngokumnika ehhovisi likadokotela, isikhungo sokungeniswa, noma isilungiselelo esibhedlela.

I-IV isetshenziselwa ukunikeza umuthi. Ukumnika ngokuvamile kuthatha amahora ambalwa, ngesikhathi esifanayo isiguli sihlolwe ukusabela okubi.

Yize kudingekile ukuba uqaphele imiphumela engaba khona, kubalulekile futhi ukuqonda ukuthi isidakamizwa asibangeli wonke umphumela ohlangothini kuwo wonke umuntu owuthathayo. Lena nje uhlu lwemiphumela emibi ebikwe ngabantu abathwala i-Remicade, noma odokotela babo. Abantu baqokwe le mithi ngoba kubalulekile ukuvimbela i-IBD ukuthi ingabangela ukuvuvukala emgodini wokugaya, okungabangela izinkinga. Uma uhlangabezana nomthelela ohlangothini ngesikhathi sokumnika, khuluma nabahlengikazi esibhedlela noma isikhungo sokumnika isikhashana ngokushesha. Uma uthola umphumela wecala kamuva, qiniseka ukuthi uxoxisane nodokotela oye wabeka i-Remicade.

Isexwayiso se-FDA Black Box

I-Remicade inakho lokho i-FDA ibiza khona isixwayiso se-Black Box. Lokhu kusho ukuthi phezulu kwepakethe yolwazi lwesiguli, kunamagama akhethekile ngesibindi esungezwe ibhokisi elimnyama.

Isizathu sokuthi kungani i-Remicade inegama elikhethekile ngoba wonke umuntu othatha lesi sidakamizwa kufanele ahlolwe isifo sofuba (TB) ngaphambi kokuwamukela. Esinye isigaba sithi wonke umuntu otheleleke kakhulu akufanele athathe umuthi, noma kufanele ayeke ukuthatha uma ukutheleleka kuqhubeka. Ingxenye yokugcina ikhuluma ngezingozi ezingase zibe khona zezinhlobo ezithile zegciwane, njengezikhumba zesikhumba kanye ne-lymphoma.

Lokhu kuzwakala kunesabekayo, kodwa ingozi yomdlavuza kucatshangwa ukuthi iphansi kakhulu.

Okulandelako kungenye yemiphumela emibi ye-Remicade. Akuwona wonke umphumela osebenzayo, kanti ezinye zazo azivamile. Uma unenkinga mayelana nemiphumela emibi, khuluma nabo nge- gastroenterologist yakho.

Yazisa njalo uDokotela

Uma unomunye wale mphumela ohlangothini, uzofuna ukuvumela udokotela wakho wazi.

Imiphumela emibi evame kakhulu:

Imiphumela emibi engavamile:

Imiphumela emibi engavamile:

Imiphumela Yomphumela Okumele Yenziwe Ngokushesha

Uma uneminye yemiphumela emibi, khuluma nochwepheshe wezempilo wezempilo ngokushesha, ungalindeli ukuqokwa kwakho okulandelayo.

Imiphumela emibi evame kakhulu:

Ezinye imiphumela emibi engabhalwanga ngenhla zingase zenzeke kwezinye iziguli. Uma ubona noma yimiphi imiphumela, hlola nodokotela wakho. Lolu lwazi luqondiswa kuphela njengeseluleko - njalo uxoxe nodokotela noma wemithi ukuze uthole ulwazi oluphelele mayelana nemithi yokwelashwa.

Umthombo:

I-Janssen Biotech, Inc. REMICADE® (i-infliximab) . "I-Remicade.com. Ngo-Okthoba 2015. 4 Feb 2016.